Nanobiotix S.A. Adjustments For Increase Decrease In Derivative Financial Liabilities
Nanobiotix S.A. (NNBXF) reported Adjustments For Increase Decrease In Derivative Financial Liabilities of EUR 6.79 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities · last filed 2026-03-31
| Period end | Adjustments For Increase Decrease In Derivative Financial Liabilities 6 month | Adjustments For Increase Decrease In Derivative Financial Liabilities 12 month |
|---|---|---|
| 2025-12-31 | 6.79M EUR 20-F · filed 2026-03-31 | |
| 2025-06-30 | 2.37M EUR 6-K · filed 2025-09-30 | |
| 2024-12-31 | 3.31M EUR 20-F · filed 2026-03-31 | |
| 2024-06-30 | 37.00K EUR 6-K · filed 2025-09-30 | |
| 2023-12-31 | 4.98M EUR 20-F · filed 2026-03-31 | |
| 2023-06-30 | 2.00M EUR 6-K · filed 2024-09-18 | |
| 2022-12-31 | 10.65M EUR 20-F · filed 2025-04-02 | |
| 2022-06-30 | 1.67M EUR 6-K · filed 2023-09-26 | |
| 2021-12-31 | -1.55M EUR 20-F · filed 2024-04-24 | |
| 2021-06-30 | 2.05M EUR 6-K · filed 2022-09-28 | |
| 2020-12-31 | -6.46M EUR 20-F · filed 2023-04-24 | |
| 2019-12-31 | 2.83M EUR 20-F · filed 2022-04-08 |